Trump Issues Executive Order to Narrow U.S. Childhood Vaccine Schedule, Despite Court Injunction

President Donald Trump on Friday issued an executive order aimed at pushing the United States toward a narrower childhood vaccine schedule modeled on what the administration calls practices in “peer, developed countries,” even as the administration’s earlier effort to make those changes is still blocked by a federal court.

The May 29 order, titled “Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries,” builds on a Dec. 5, 2025, presidential memorandum that told federal health agencies to examine whether U.S. childhood vaccine recommendations should be aligned with comparable nations. It directs the Centers for Disease Control and Prevention and its Advisory Committee on Immunization Practices, or ACIP, to review a previously issued Health and Human Services Department scientific assessment and, “to the extent permitted by law,” take steps to update the childhood and adolescent vaccine schedule. The order also tells agencies to give parents and clinicians “maximum flexibility” in vaccine timing and sequencing, while saying vaccines that remain on a CDC schedule category should continue to be covered without cost sharing by private insurance, Medicaid, the Children’s Health Insurance Program and the Vaccines for Children program.

The White House framed the move as both a scientific and parental-rights measure. “My Administration is committed to ensuring that Americans are receiving the best scientifically supported medical advice in the world. Additionally, my Administration is committed to protecting religious liberty and parental authority,” the order said.

The executive action follows a Jan. 2, 2026, HHS scientific assessment, “Assessment of the U.S. Childhood and Adolescent Immunization Schedule Compared to Other Countries.” The assessment, authored by Tracy Beth Høeg, M.D., Ph.D., and Martin Kulldorff, Ph.D., in consultation with experts from the CDC, Food and Drug Administration, National Institutes of Health and Centers for Medicare and Medicaid Services, said the United States in 2024 recommended protection against 18 diseases and at least 84 vaccine doses. It argued that the country was an outlier among peer nations in both the number of recommended vaccines and doses, and recommended narrowing the routine “core” schedule to what it called “consensus vaccines”: measles, mumps, rubella, polio, pertussis, tetanus, diphtheria, Hib, pneumococcus, HPV and varicella.

Three days later, on Jan. 5, acting CDC Director Jim O’Neill signed a decision memorandum accepting those recommendations and directing the agency to implement a three-part framework: vaccines recommended for all children, for certain high-risk groups, and for shared clinical decision-making between families and clinicians. One of the most visible changes had already come at ACIP’s Dec. 4-5, 2025, meeting, when the panel voted 8-3 to move the hepatitis B birth dose for infants born to mothers who test negative for hepatitis B from a universal recommendation to an individual-based, shared clinical decision-making category. Major medical groups, including the American Academy of Pediatrics, criticized that shift and later sued.

That litigation now sharply limits the order’s immediate practical effect. On March 16, U.S. District Judge Brian E. Murphy in Massachusetts granted a preliminary injunction in American Academy of Pediatrics et al. v. Kennedy et al. The ruling stayed the January 2026 memorandum revising the CDC childhood immunization schedule, stayed the appointments of 13 ACIP members appointed in 2025 and 2026, and stayed all votes taken by the challenged ACIP. Murphy wrote: “The Court concludes that the reconstitution of ACIP and the January 2026 changes to the childhood immunization schedule violate the Administrative Procedure Act.”

The court said the plaintiffs were likely to succeed on claims under the Administrative Procedure Act, the federal law governing agency decision-making, and the Federal Advisory Committee Act, which sets rules for advisory panels. As of Friday, the injunction remained in effect, and HHS had appealed to the U.S. Court of Appeals for the First Circuit.

That means Trump’s new order is a significant policy statement, but it does not free the blocked January schedule changes to take effect. Instead, it formalizes the administration’s preferred direction while the courts continue to determine whether the earlier CDC and HHS actions were lawful.

The fight matters because ACIP recommendations are not just advisory in a loose sense. Once the CDC adopts them, they generally drive no-cost vaccine coverage under the Affordable Care Act and shape coverage in Medicaid, CHIP and the Vaccines for Children program. The CDC said in January that “All vaccines currently recommended by CDC will remain covered by insurance without cost sharing.”

At the same time, federal vaccine recommendations do not automatically rewrite school requirements. States, not the federal government, set most school-entry vaccine mandates. So the administration’s effort is chiefly about the federal schedule that guides insurance coverage, access and clinical practice — and for now, the January changes at the center of that effort remain under court order.